TP53 and B-cell chronic lymphocytic leukemia: 17p deletion and complex karyotypes occur during disease progression, leading to the conventional view of CLL with a single TP53 mutation associated with TP53 loss of heterozygosity (LOH) (Figure 4, panel 3).